CSIMarket Company Name, Ticker, Competitors, else..


Crispr Therapeutics Ag  (NASDAQ: CRSP)
Other Ticker:  
 

Crispr Therapeutics Ag

CRSP's Fundamental analysis



Looking into Crispr Therapeutics Ag growth rates, revenue grew by 71.63 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 59

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 11.44 %

Crispr Therapeutics Ag net loss increased from $-117 millions, to $-136 millions in first quarter of 2025,

• More on CRSP's Growth


Crispr Therapeutics Ag
realized a net loss in trailing twelve months.

Crispr Therapeutics Ag realized cash reduction of $ -5.5 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 81.21.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.87.


• More on CRSP's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 95,865
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 21.28

Crispr Therapeutics Ag
realized net loss in trailing twelve months.

Crispr Therapeutics Ag realized cash outflow of $ -5.5per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 81.21.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.87.

Crispr Therapeutics Ag Price to Book Ratio is at 1.67 higher than Industry Avg. of -86753.11, and higher than S&P 500 Avg. of 0.01

• More on CRSP's Valuation

•  Market Capitalization (Millions $) 3,059
•  Shares Outstanding (Millions) 86
•  Employees 393
•  Revenues (TTM) (Millions $) 38
•  Net Income (TTM) (Millions $) -386
•  Cash Flow (TTM) (Millions $) -472
•  Capital Exp. (TTM) (Millions $) -1
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 95,865
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 21.28

•  Market Capitalization (Millions $) 3,059
•  Shares Outstanding (Millions) 86
•  Employees 393
•  Revenues (TTM) (Millions $) 38
•  Net Income (TTM) (Millions $) -386
•  Cash Flow (TTM) (Millions $) -472
•  Capital Exp. (TTM) (Millions $) -1





  Ratio
•   Capital Ratio (MRQ) 15.64
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.18
•  Asset Turnover Ratio (TTM) 0.02
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com